MICHELLE MEADOWS: Open Payments
NPI 1619365269 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 9 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $0 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| United Therapeutics Corporation | 1 | $26 |
| Verona Pharma, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
Products named: FASENRA, GLASSIA, NUCALA, Tyvaso, Ohtuvayre, OPSYNVI.
Industry payments across FL — which companies pay providers there.
